Dr Silvia Oggero
Post Doctoral Research Assistant
Biochemical Pharmacology, The William Harvey Research Institute
Queen Mary University of London
Queen Mary University of London
Research
Interests
interest and expertise in all in vitro models which wil mimick inflammation and are crucial in the resolution process in various chronic diseases.Publications
2020
Imbalance of proresolving lipid mediators in
persistent allodynia dissociated from signs of
clinical arthritisAllen BL, Montague-Cardoso K, Simeoli R, Colas RA, Oggero S, Vilar B, McNaughton PA, Dalli J, Perretti M, Sher E and Malcangio M
Pain, Lippincott, Williams & Wilkins
04-05-2020
Immuno-moodulin: A new anxiogenic factor produced by Annexin-A1 transgenic autoimmune-prone T cellsPiras G, Rattazzi L, Paschalidis N, Oggero S, Berti G, Ono M, Bellia F, D'Addario C, Dell'Osso B, Pariante CM, Perretti M and D'Acquisto F
Brain Behavior and Immunity, Elsevier vol. 87, 689-702.
29-02-2020
2019
The contrasting role of extracellular vesicles in vascular inflammation and tissue repairOggero S, Austin-Williams S and Norling LV
Frontiers in Pharmacology, Frontiers Media vol. 10
17-12-2019
2018
Microvesicle Subsets in Sepsis Due to Community Acquired Pneumonia Compared to Faecal Peritonitis.Lashin HMS, Nadkarni S, Oggero S, Jones HR, Knight JC, Hinds CJ and Perretti M
Shock vol. 49 (4), 393-401.
01-04-2018
2016
The synthetic antimicrobial peptide 19-2.5 attenuates septic cardiomyopathy and prevents down-regulation of SERCA2 in polymicrobial sepsisMartin L, Horst K, Chiazza F, Oggero S, Collino M, Brandenburg K, Hildebrand F, Marx G, Thiemermann C and Schuerholz T
Scientific Reports vol. 6
17-11-2016